Literature DB >> 9616537

Fluticasone propionate: an audit of outcomes and cost-effectiveness in primary care.

D B Price1, J L Appleby.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9616537     DOI: 10.1016/s0954-6111(98)90120-2

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


× No keyword cloud information.
  3 in total

Review 1.  Inhaled fluticasone propionate. A pharmacoeconomic review of its use in the management of asthma.

Authors:  H M Lamb; C R Culy; D Faulds
Journal:  Pharmacoeconomics       Date:  2000-11       Impact factor: 4.981

2.  Cost-efficacy analysis of fluticasone propionate versus zafirlukast in patients with persistent asthma.

Authors:  R Menendez; R H Stanford; L Edwards; C Kalberg; K Rickard
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

3.  Cost Effectiveness of Pharmacological Treatments for Asthma: A Systematic Review.

Authors:  Carlos E Rodriguez-Martinez; Monica P Sossa-Briceño; Jose A Castro-Rodriguez
Journal:  Pharmacoeconomics       Date:  2018-10       Impact factor: 4.981

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.